Data shows Vx Therapy reduces chronic pain,
lowers use of medication, produces significant ROI, and improves overall recovery
without narcotics or surgery for workers’ compensation patients
Harvard MedTech, a breakthrough digital
health company, is tapping the new science of how the brain works by using
virtual reality experiences, psychosocial support, digital engagement and
proprietary AI algorithms to alleviate the effects of trauma and pain without
narcotics or surgery. Data reveals that Harvard MedTech’s Vx Therapy lowers
cost and duration of treatment, reduces risk of long-term disability, avoids
dependence on prescription drugs, and produces a significant
return-on-investment, in some documented cases even achieving ROI levels as
high as 35:1.
“We’ve demonstrated
that Vx Therapy reduces the risk of higher cost workers’ compensation claims,
the likelihood of long-term claims due to pain and psychosocial problems, and
the cost and risk of addiction to prescription medications or illegal drugs to
control pain and mood. Simply put, this breakthrough approach harnesses the
power of the brain to help restore a sense of normalcy to patients who have
suffered a trauma.”
With Vx Therapy, the patient uses the
virtual reality technology to have positive, engaging experiences that reduce
the sensation of pain while the brain builds new neural pathways. The VR
therapy is used in the home, and is coupled with personalized behavioral health
intervention strategies that teach more skills to permanently lower pain and
discomfort that contribute to depression and sleep disorders. The 90-day
program is based on the time it takes for the brain to form new neural
pathways.
With the application of digital health, Vx
Therapy is a scalable solution for employers, carriers and risk managers to
manage patient populations and contain costs.
In a recent study, a group of 36 patients
with chronic debilitating pain from workplace injuries participated in Harvard
MedTech’s Vx Therapy program. Results showed pain levels were reduced an
average of 40% while wearing the headsets, and on average, patients experienced
2.8 hours of relief post treatment, categorized as legacy pain relief.
Medication usage was also tracked, and over the course of the program, 69% of
patients reported either a decrease (31%) or a complete cessation (38%) of
opiate use. Decreased pain levels along with reduced medication usage show the
effectiveness of Vx Therapy as an immediate, fast-acting method of pain relief
with equal or greater pain reduction than opioids without the undesirable side
effects. Perhaps most importantly, patients in the study became more pain
resilient and learned to function better, largely in part to their reduced
levels of pain. Patients were able to experience discomfort without a spike in
anxiety, indicating that their psychological well-being was improving, and they
were better prepared to be reintegrated into daily life.
Vx Therapy is now being used by major
medical institutions and workers’ compensation organizations to manage care for
patients who are suffering with chronic pain, behavioral health issues and
other symptoms of trauma. For more information, contact Pat McCutcheon,
PMcCutcheon@harvardmedtech.com, 516-946-7938.
About Harvard MedTech
Harvard MedTech is a breakthrough digital health company that is tapping the new science of how the brain works, combining specially designed virtual reality experiences, psychosocial support, digital engagement and proprietary AI algorithms to retrain neural pathways and alleviate the effects of trauma, including pain, PTSD, anxiety, depression and sleep disorders. The company’s Vx Therapy model is the first to comprehensively integrate this unique combination of digital technologies with behavioral health interventions, in a virtual application that moves the points of care to the patient’s home. This virtual engagement drives high compliance, patient satisfaction and optimal outcomes. It also allows the solution to be affordable and scalable at a population health level. This non-invasive and non-pharmacological approach also provides data that is trackable for a clear assess of its value to patient and health care providers. Visit www.harvardmedtech.com for more information.
